Evaluating MCM3 Expression as a Diagnostic and Prognostic Marker in Oral Epithelial Dysplasia and OSCC: A Systematic Review | Synapse
March 3, 2026
Evaluating MCM3 Expression as a Diagnostic and Prognostic Marker in Oral Epithelial Dysplasia and OSCC: A Systematic Review
Key Points
MCM3 expression serves as a promising marker for early diagnosis in oral epithelial dysplasia and oral squamous cell carcinoma.
The systematic review consolidates findings from multiple sources supporting MCM3's relevance, including a significant correlation with disease progression.
Assessment of MCM3 expression utilizes various methodologies to establish its effectiveness in distinguishing between dysplastic lesions and malignant tumors.
Further studies are needed to validate the clinical implications of MCM3 as a routine diagnostic tool in oral health care.